New Treatment Launched to Help Improve Symptoms in People Suffering From Overactive Bladder | Health Informer: "Pfizer Limited has launched Toviaz(R)(Black Triangle Drug) (fesoterodine fumarate), a new once daily treatment for the symptoms of overactive bladder (OAB). OAB is a condition which affects an estimated 4.9 million people in the UK(1) (more than twice the number of people with diabetes(2)) and has been shown to have a serious and detrimental effect on people’s emotional, psychological and sexual wellbeing(3)."
No comments:
Post a Comment